GPX3 and COVID-19: In contrast, GPX3 was decreased in COVID-19 patients with comorbidities—consistent with previous reports—which revealed lower glutathione peroxidase activity due to the SARS-CoV-2 infection [52] as well as Epstein–Barr virus infection in diabetic patients [53].